PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 2002Medical Care773 citations

Overview of the SEER-Medicare Data

View Full Paper
JWJoan L. WarrenAmerican Cancer SocietyCKCarrie N. KlabundeNational Institutes of Health
Deborah Schrag
Deborah SchragMemorial Sloan Kettering Cancer Center

Key Points

Key points are not available for this paper at this time.

Abstract

Background. The Surveillance, Epidemiology and End Results (SEER)-Medicare–linked database combines clinical information from population-based cancer registries with claims information from the Medicare program. The use of this database to study cancer screening, treatment, outcomes, and costs has grown in recent years. Research Design. This paper provides an overview of the SEER-Medicare files for investigators interested in using these data for epidemiologic and health services research. The overview includes a description of the linkage of SEER and Medicare data and the files included as part of SEER-Medicare. The paper also describes the types of research projects that have been undertaken using the SEER-Medicare data. The overview concludes with a comparison of selected characteristics of elderly persons residing in the SEER areas to the US total aged. Results. The paper identifies a number of potential uses of the SEER-Medicare data. The comparison of the elderly population in SEER areas to the US total shows that in the SEER areas there are a lower percentage of white persons and individuals living in poverty, and a higher percentage of urban-dwellers than the US total. Elderly persons in the SEER regions also have higher rates of HMO enrollment and lower rates of cancer mortality. Conclusions. The SEER-Medicare data are a unique resource that can be used for a variety of health services research projects. Although there are some differences between the elderly residing in the SEER areas and the US total, the SEER-Medicare data offer a large population-based cohort that can be used to longitudinally track care for persons over the course of cancer diagnosis, treatment, and follow-up.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Warren et al. (2002) studied this question.

synapsesocial.com/papers/6a0ce08c004017e1a0fc0ab4https://doi.org/10.1097/00005650-200208001-00002
Ask AI
Helpful
Bookmark
Share
View Full Paper